Menon, Usha
McGuire, Alistair J
Raikou, Maria
Ryan, Andy
Davies, Susan K
Burnell, Matthew
Gentry-Maharaj, Aleksandra
Kalsi, Jatinderpal K
Singh, Naveena
Amso, Nazar N
Cruickshank, Derek
Dobbs, Stephen
Godfrey, Keith
Herod, Jonathan
Leeson, Simon
Mould, Tim
Murdoch, John
Oram, David
Scott, Ian
Seif, Mourad W
Williamson, Karin
Woolas, Robert
Fallowfield, Lesley
Campbell, Stuart
Skates, Steven J
Parmar, Mahesh
Jacobs, Ian J
Article History
Received: 6 October 2016
Revised: 23 May 2017
Accepted: 21 June 2017
First Online: 25 July 2017
Competing interests
: IJJ–Abcodia Ltd (Non-Executive Director and Consultant)–personal fees, stock ownership. Director–Women’s Health Specialists–personal fees. Patent ROC algorithm–institutional license to Abcodia with royalty agreement. Trustee (2012–2104) and Emeritus Trustee (2015–to date) for The Eve Appeal. Grants received from the MRC, CRUK, NIHR, Eve Appeal. UM–stock ownership and research funding from Abcodia. Grants received from the MRC, CRUK, NIHR, Eve Appeal. NA–Medaphor plc–Spin-off company at Cardiff University–founder, stock ownership and Board member. Patent: Ultrasound simulation training system MEDAPHOR, 12 October 2011. AL–reports personal fees from Roche as a panel member and advisory board member and fees from SPMSD (Gardasil) as an advisory board member. JM–private ovarian cancer screening programme following closure of the trial. MWS–personal fees–consultancy to Abcodia. LJF–funding from MRC for UKCTOCS Psychosocial study. Personal fees from GSK, Amgem, Astrazeneca, Roche, Pfzier, TEVA, Bristol Myers Squibb and Sanofi. Grants from Boehringer-Ingelheim and Roche. SJS–personal fees–LUNGevity and SISCAPA Assay Technologies as a member of the Scientific Advisory Board. Personal fees–Abcodia as a consultant, Astra-Zeneca as a speaker honorarium. Patent ROC algorithm–institutional license to Abcodia. The other authors declare no conflict of interest.